HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gianluca Molla Selected Research

D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)

3/2013Characterization of human DAAO variants potentially related to an increased risk of schizophrenia.
1/2013D-amino acid oxidase inhibitors as a novel class of drugs for schizophrenia therapy.
11/2011Is rat an appropriate animal model to study the involvement of D-serine catabolism in schizophrenia? Insights from characterization of D-amino acid oxidase.
8/2010Effect of ligand binding on human D-amino acid oxidase: implications for the development of new drugs for schizophrenia treatment.
11/2009Optimization of human D-amino acid oxidase expression in Escherichia coli.
9/2009Optimization of D-amino acid oxidase for low substrate concentrations--towards a cancer enzyme therapy.
4/2009Relevance of weak flavin binding in human D-amino acid oxidase.
8/2008pLG72 modulates intracellular D-serine levels through its interaction with D-amino acid oxidase: effect on schizophrenia susceptibility.
4/2006Characterization of human D-amino acid oxidase.
3/2006Expression in Escherichia coli and in vitro refolding of the human protein pLG72.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gianluca Molla Research Topics

Disease

15Schizophrenia (Dementia Praecox)
01/2021 - 03/2006
3Glioblastoma (Glioblastoma Multiforme)
03/2013 - 08/2008
2Neoplasms (Cancer)
09/2009 - 02/2008
1succinic semialdehyde dehydrogenase deficiency
11/2020
1Alzheimer Disease (Alzheimer's Disease)
01/2020
1Neuroblastoma
10/2017
1Motor Neuron Disease (Primary Lateral Sclerosis)
01/2017
1Central Nervous System Diseases (CNS Diseases)
09/2015
1Prostatic Neoplasms (Prostate Cancer)
08/2014
1Neoplasm Metastasis (Metastasis)
08/2014
1Neurobehavioral Manifestations
01/2013
1Bipolar Disorder (Manic Depressive Psychosis)
11/2012
1Epilepsy (Aura)
11/2012
1Mental Disorders (Mental Disorder)
03/2006

Drug/Important Bio-Agent (IBA)

10D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA
03/2013 - 03/2006
9Serine (L-Serine)FDA Link
09/2015 - 04/2006
4N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2021 - 04/2009
4EnzymesIBA
03/2013 - 02/2008
3Neurotransmitter Agents (Neurotransmitter)IBA
11/2020 - 11/2012
3Proteins (Proteins, Gene)FDA Link
01/2018 - 01/2016
2D-Aspartic Acid (D Aspartate)IBA
01/2021 - 01/2020
2N-Methylaspartate (NMDA)IBA
11/2011 - 04/2006
2Glutamate Receptors (Glutamate Receptor)IBA
11/2011 - 04/2006
2FlavoproteinsIBA
11/2009 - 04/2009
1gamma-Aminobutyric Acid (GABA)IBA
11/2020
1Butyric Acid (Butanoic Acid)IBA
11/2020
1Messenger RNA (mRNA)IBA
01/2018
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
10/2017
1Oxidopamine (6 Hydroxydopamine)IBA
10/2017
1Pharmaceutical PreparationsIBA
01/2017
1Sarcosine (Methylglycine)IBA
08/2014
1Protein AggregatesIBA
03/2013
1Flavin-Adenine Dinucleotide (FAD)IBA
01/2013
1Antipsychotic Agents (Antipsychotics)IBA
01/2013
1serine racemaseIBA
01/2013
1LigandsIBA
08/2010
1ProdrugsIBA
09/2009
1Cephalosporins (Cephalosporin Antibiotics)IBA
02/2008
1cephalosporin CIBA
02/2008

Therapy/Procedure

3Therapeutics
01/2021 - 09/2009
1Oral Administration
01/2013
1Enzyme Therapy
09/2009